Ignite Creation Date:
2025-12-26 @ 11:10 AM
Ignite Modification Date:
2026-01-01 @ 2:26 AM
Study NCT ID:
NCT03518112
Status:
TERMINATED
Last Update Posted:
2022-11-04
First Post:
2018-04-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Low-Intensity Chemotherapy and Blinatumomab in Treating Patients With Philadelphia Chromosome Negative Relapsed or Refractory Acute Lymphoblastic Leukemia
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-04-18
Start Date Type:
ACTUAL
Primary Completion Date:
2021-05-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-05-27
Completion Date Type:
ACTUAL
First Submit Date:
2018-04-25
First Submit QC Date:
None
Study First Post Date:
2018-05-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-05-17
Results First Submit QC Date:
None
Results First Post Date:
2022-11-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-03
Last Update Post Date:
2022-11-04
Last Update Post Date Type:
ACTUAL